Clinical Practice Guideline on Melanoma From the Spanish Academy of Dermatology and Venereology (AEDV)

• DOI: 10.1016/j.adengl.2020.07.005
• Publication Date: 2020-12-29T02:16:16Z
• Authors: R. Botella-Estrada; A. Boada-García; C. Carrera-Álvarez; M. Fernández-Figu...; M. González-Cao; D. Moreno-Ramírez; E. Nagore; L. Ríos-Buceta; J.L. Rodríguez-Pe...; E. Samaniego-Gonz...; A. Tejera-Vaquerizo; F. Vílchez-Márquez; M.A. Descalzo-Gal...; I. García-Doval
• Keywords: Practice guideline; Skin Neoplasms; Biopsy; Terapéutica; Antineoplastic Agents; Therapeutics; Hutchinson's Melanotic Freckle; 03 medical and health sciences; 0302 clinical medicine; Diagnòstic; Diagnosis; Humans; Neoplasm Metastasis; Melanoma; Neoplasm Staging; Evidence-Based Medicine; Sentinel Lymph Node Biopsy; Diagnóstico; Disease Management; Diagnosis, Diagnóstico, Guía de práctica clínica, Melanoma, Practice guideline, Terapéutica, Therapeutics; Terapèutica; Combined Modality Therapy; Guía de práctica clínica; Molecular Diagnostic Techniques; dermatologia

Specialist approaches to the diagnosis and treatment of melanoma have undergone many changes. This guideline aims to provide Spanish dermatologists with evidence-based information for resolving the most common doubts that arise in clinical practice. Members of the Spanish Oncologic Dermatology and Surgery Group (GEDOC) with experience treating melanoma were invited to participate in drafting the guideline. The group developed a new guideline on the basis of existing ones, using the ADAPTE collaboration process, first summarizing the care process and posing relevant clinical questions, then selecting guidelines with the best scores according to the AGREE II (Appraisal of Guidelines for Research and Evaluation) tool. Finally, the group searched the selected guidelines for answers to the clinical questions, drafted recommendations, and sent them for external review. The guideline is structured around 21 clinical questions chosen for their relevance to issues that make clinical decisions about the management of melanoma difficult. Evidence from existing guidelines was used to answer the questions. A limitation of this guide derives from the scarce evidence available for answering some questions. Moreover, some areas are changing rapidly, so recommendations must be updated often. The present guideline offers answers to clinical questions about the routine management of melanoma in clinical practice and provides dermatologists with a reference to guide decisions, taking into consideration the resources available and patient preferences.